Fell; Jay Bradford
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fell; Jay Bradford.The latest application filed is for "protein tyrosine phosphatase inhibitors".
Company Profile
9.20.26
- Fell; Jay Bradford - Longmont CO
- FELL; Jay Bradford - Denver CO
- Fell; Jay Bradford - Boulder CO
Patent Activity
| Patent | Date |
|---|---|
| KRas G12D inhibitors Grant 11,453,683 - Wang , et al. September 27, 2 | 2022-09-27 |
| Protein Tyrosine Phosphatase Inhibitors App 20220251083 - BLAKE; James Francis ; et al. | 2022-08-11 |
| KRAS G12C inhibitors Grant 11,267,812 - Fischer , et al. March 8, 2 | 2022-03-08 |
| Protein Tyrosine Phosphatase Inhibitors App 20210380582 - BLAKE; James Francis ; et al. | 2021-12-09 |
| Kras G12c Inhibitors App 20210380570 - Marx; Matthew Arnold ; et al. | 2021-12-09 |
| Kras G12c Inhibitors App 20210269432 - FISCHER; John P. ; et al. | 2021-09-02 |
| Kras G12c Inhibitors App 20210230170 - Marx; Matthew Arnold ; et al. | 2021-07-29 |
| 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Grant 11,028,093 - Allen , et al. June 8, 2 | 2021-06-08 |
| Protein Tyrosine Phosphatase Inhibitors App 20200317665 - BLAKE; James F. ; et al. | 2020-10-08 |
| 4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS App 20200291039 - Allen; Shelley ; et al. | 2020-09-17 |
| 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors Grant 10,730,880 - Allen , et al. | 2020-08-04 |
| KRas G12C inhibitors Grant 10,689,377 - Blake , et al. | 2020-06-23 |
| KRas G12C inhibitors Grant 10,633,381 - Blake , et al. | 2020-04-28 |
| 4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS App 20190177328 - Allen; Shelley ; et al. | 2019-06-13 |
| Kras G12c Inhibitors App 20190144444 - Blake; James F. ; et al. | 2019-05-16 |
| Kras G12c Inhibitors App 20190062330 - Blake; James F. ; et al. | 2019-02-28 |
| 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors Grant 10,189,845 - Allen , et al. Ja | 2019-01-29 |
| KRas G12C inhibitors Grant 10,125,134 - Blake , et al. November 13, 2 | 2018-11-13 |
| Kras G12c Inhibitors App 20180072723 - Blake; James F. ; et al. | 2018-03-15 |
| 4,6-SUBSTITUTED-PYRAZOLO[1,5-a]PYRAZINES AS JANUS KINASE INHIBITORS App 20170362240 - Allen; Shelley ; et al. | 2017-12-21 |
| Intermediates for the preparation of pyridin-2-yl-amino-1,2,4-thiadiazole derivatives Grant 9,079,890 - Aicher , et al. July 14, 2 | 2015-07-14 |
| Intermediates For The Preparation Of Pyridin-2-yl-amino-1,2,4-thiadiazole Derivatives App 20150057448 - Aicher; Thomas Daniel ; et al. | 2015-02-26 |
| Substituted pyrazolo[1,5-a]pyrimidine compounds as mTOR inhibitors Grant 8,865,726 - Andrews , et al. October 21, 2 | 2014-10-21 |
| Piperidinyl-substituted Cyclic Ureas As Gpr119 Modulators App 20140309226 - Fell; Jay Bradford ; et al. | 2014-10-16 |
| Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus Grant 8,853,409 - Aicher , et al. October 7, 2 | 2014-10-07 |
| Piperidinyl-substituted Lactams As Gpr119 Modulators App 20140256756 - Aicher; Thomas Daniel ; et al. | 2014-09-11 |
| Piperidinyl-substituted lactams as GPR119 modulators Grant 8,754,226 - Aicher , et al. June 17, 2 | 2014-06-17 |
| Piperidinyl-substituted Lactams As Gpr119 Modulators App 20130184257 - Aicher; Thomas Daniel ; et al. | 2013-07-18 |
| Piperidinyl-substituted Lactams As Gpr119 Modulators App 20130158009 - Aicher; Thomas Daniel ; et al. | 2013-06-20 |
| Pyridin-2YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus App 20120277242 - AICHER; Thomas Daniel ; et al. | 2012-11-01 |
| SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS App 20120178715 - Andrews; Steven W. ; et al. | 2012-07-12 |
| Pyridin-2-yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus Grant 8,212,045 - Aicher , et al. July 3, 2 | 2012-07-03 |
| Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus App 20100204240 - Aicher; Thomas Daniel ; et al. | 2010-08-12 |
| 1,1-dioxo-1H-1.LAMBDA..sup.6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydr- o-pyrrol-2-one inhibitors of HCV polymerase Grant 7,674,810 - Blake , et al. March 9, 2 | 2010-03-09 |
| Heterocyclic antiviral compounds Grant 7,531,534 - Fell , et al. May 12, 2 | 2009-05-12 |
| Heterocyclic antiviral compounds Grant 7,479,489 - Blake , et al. January 20, 2 | 2009-01-20 |
| Heterocyclic antiviral compounds App 20080095739 - Fell; Jay Bradford ; et al. | 2008-04-24 |
| Heterocyclic antiviral compounds App 20060252785 - Blake; James F. ; et al. | 2006-11-09 |
| Heterocyclic antiviral compounds App 20060040927 - Blake; James F. ; et al. | 2006-02-23 |
| Arylsulfonamide ethers, and methods of use thereof Grant 6,875,765 - Knobelsdorf , et al. April 5, 2 | 2005-04-05 |
| Arylsulfonamide ethers, and methods of use thereof App 20030096826 - Knobelsdorf, James ; et al. | 2003-05-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 